Cerity Partners
AUPH icon

Cerity Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cerity Partners’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Sell
24,029
-2,366
-9% -$37.8K ﹤0.01% 2559
2026
Q1 		$391K Buy
26,395
+14,950
+131% +$219K ﹤0.01% 2430
2025
Q4 		$183K Sell
11,445
-3,644
-24% -$51.7K ﹤0.01% 2658
2025
Q3 		$167K Buy
+15,089
New +$165K ﹤0.01% 2547
2025
Q2 		– Sell
-11,981
Closed -$96.3K – 2637
2025
Q1 		$96.3K Buy
+11,981
New +$97.1K ﹤0.01% 2327

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Cerity Partners's AUPH Position: Q2 2026 in Review

Cerity Partners reduced its Aurinia Pharmaceuticals (AUPH) stake by 9% in Q2 2026, selling an estimated $37.8K and leaving 24,029 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #2559.

Cerity Partners first reported a position in AUPH in Q1 2025 and has held it in 5 quarters since. 245 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Cerity Partners held 24,029 shares of Aurinia Pharmaceuticals worth $408K as of Q2 2026.
  • Cerity Partners sold 2,366 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $37.8K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2559 holding.
  • Cerity Partners first reported a position in Aurinia Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 245 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.